(WT) WisdomTree - Ratings and Ratios
ETFs, Index Licensing, 401(k) Platform, Advisory
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.11% |
| Yield on Cost 5y | 2.45% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 87.4% |
| Payout Ratio | 16.2% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 34.6% |
| Value at Risk 5%th | 54.5% |
| Relative Tail Risk | -4.27% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.42 |
| Alpha | 39.62 |
| CAGR/Max DD | 1.09 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.511 |
| Beta | 1.148 |
| Beta Downside | 1.275 |
| Drawdowns 3y | |
|---|---|
| Max DD | 37.13% |
| Mean DD | 9.78% |
| Median DD | 7.30% |
Description: WT WisdomTree January 14, 2026
WisdomTree, Inc. (NYSE:WT) is an ETF sponsor and asset manager that offers exchange-traded funds across equities, currencies, fixed income, and alternative asset classes, while also licensing its fundamentally weighted indexes to third-party product providers and supporting the inclusion of its ETFs in 401(k) plans.
As of FY 2023, WisdomTree reported approximately $110 billion in assets under management (AUM), a 15% year-over-year revenue increase driven largely by higher inflows into its fixed-income and “smart beta” equity products; however, fee compression in the broader ETF market and a rising interest-rate environment remain material risks to future growth. The firm’s core differentiator-fundamentally weighted indexing-has gained traction as investors seek alternatives to market-cap weighting, especially in a period where macro-economic uncertainty is prompting a shift toward income-focused and lower-volatility strategies.
For a deeper quantitative breakdown of WisdomTree’s valuation metrics, see the ValueRay profile.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (96.4m TTM) > 0 and > 6% of Revenue (6% = 27.4m TTM) |
| FCFTA 0.09 (>2.0%) and ΔFCFTA -2.21pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 101.1% (prev 49.20%; Δ 51.88pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.09 (>3.0%) and CFO 127.8m > Net Income 96.4m (YES >=105%, WARN >=100%) |
| Net Debt (400.4m) to EBITDA (147.0m) ratio: 2.72 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.82 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (146.4m) change vs 12m ago 1.69% (target <= -2.0% for YES) |
| Gross Margin 65.39% (prev 73.72%; Δ -8.32pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 37.06% (prev 40.01%; Δ -2.95pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 5.75 (EBITDA TTM 147.0m / Interest Expense TTM 25.0m) >= 6 (WARN >= 3) |
Altman Z'' 3.48
| (A) 0.32 = (Total Current Assets 716.4m - Total Current Liabilities 254.4m) / Total Assets 1.45b |
| (B) 0.13 = Retained Earnings (Balance) 185.0m / Total Assets 1.45b |
| (C) 0.12 = EBIT TTM 143.8m / Avg Total Assets 1.23b |
| (D) 0.18 = Book Value of Equity 189.1m / Total Liabilities 1.07b |
| Total Rating: 3.48 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 73.37
| 1. Piotroski 4.50pt |
| 2. FCF Yield 5.10% |
| 3. FCF Margin 27.81% |
| 4. Debt/Equity 2.56 |
| 5. Debt/Ebitda 2.72 |
| 6. ROIC - WACC (= 2.15)% |
| 7. RoE 23.60% |
| 8. Rev. Trend 94.22% |
| 9. EPS Trend 81.70% |
What is the price of WT shares?
Over the past week, the price has changed by +11.47%, over one month by +25.29%, over three months by +16.26% and over the past year by +55.01%.
Is WT a buy, sell or hold?
- Strong Buy: 3
- Buy: 0
- Hold: 2
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the WT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 15.5 | 2% |
| Analysts Target Price | 15.5 | 2% |
| ValueRay Target Price | 20.6 | 35.8% |
WT Fundamental Data Overview January 17, 2026
P/E Forward = 15.456
P/S = 4.5772
P/B = 5.3585
Revenue TTM = 457.0m USD
EBIT TTM = 143.8m USD
EBITDA TTM = 147.0m USD
Long Term Debt = 805.1m USD (from longTermDebt, last quarter)
Short Term Debt = 150.6m USD (from shortTermDebt, last quarter)
Debt = 956.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 400.4m USD (from netDebt column, last quarter)
Enterprise Value = 2.49b USD (2.09b + Debt 956.2m - CCE 555.9m)
Interest Coverage Ratio = 5.75 (Ebit TTM 143.8m / Interest Expense TTM 25.0m)
EV/FCF = 19.61x (Enterprise Value 2.49b / FCF TTM 127.1m)
FCF Yield = 5.10% (FCF TTM 127.1m / Enterprise Value 2.49b)
FCF Margin = 27.81% (FCF TTM 127.1m / Revenue TTM 457.0m)
Net Margin = 21.10% (Net Income TTM 96.4m / Revenue TTM 457.0m)
Gross Margin = 65.39% ((Revenue TTM 457.0m - Cost of Revenue TTM 158.2m) / Revenue TTM)
Gross Margin QoQ = 55.31% (prev 70.85%)
Tobins Q-Ratio = 1.72 (Enterprise Value 2.49b / Total Assets 1.45b)
Interest Expense / Debt = 0.89% (Interest Expense 8.47m / Debt 956.2m)
Taxrate = 33.26% (9.82m / 29.5m)
NOPAT = 96.0m (EBIT 143.8m * (1 - 33.26%))
Current Ratio = 2.82 (Total Current Assets 716.4m / Total Current Liabilities 254.4m)
Debt / Equity = 2.56 (Debt 956.2m / totalStockholderEquity, last quarter 373.4m)
Debt / EBITDA = 2.72 (Net Debt 400.4m / EBITDA 147.0m)
Debt / FCF = 3.15 (Net Debt 400.4m / FCF TTM 127.1m)
Total Stockholder Equity = 408.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.82% (Net Income 96.4m / Total Assets 1.45b)
RoE = 23.60% (Net Income TTM 96.4m / Total Stockholder Equity 408.5m)
RoCE = 11.85% (EBIT 143.8m / Capital Employed (Equity 408.5m + L.T.Debt 805.1m))
RoIC = 9.30% (NOPAT 96.0m / Invested Capital 1.03b)
WACC = 7.15% (E(2.09b)/V(3.05b) * Re(10.15%) + D(956.2m)/V(3.05b) * Rd(0.89%) * (1-Tc(0.33)))
Discount Rate = 10.15% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -7.67%
[DCF Debug] Terminal Value 84.07% ; FCFF base≈121.1m ; Y1≈149.4m ; Y5≈254.4m
Fair Price DCF = 34.00 (EV 5.19b - Net Debt 400.4m = Equity 4.78b / Shares 140.7m; r=7.15% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 81.70 | EPS CAGR: 24.87% | SUE: 2.18 | # QB: 1
Revenue Correlation: 94.22 | Revenue CAGR: 13.10% | SUE: 1.53 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.22 | Chg30d=+0.008 | Revisions Net=+3 | Analysts=6
EPS next Year (2026-12-31): EPS=0.95 | Chg30d=+0.032 | Revisions Net=+5 | Growth EPS=+19.4% | Growth Revenue=+21.7%
Additional Sources for WT Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle